Phase I pharmacokinetic, safety, and preliminary efficacy study of tiragolumab in combination with atezolizumab in Chinese patients with advanced solid tumors.
Saved in:
| Title: | Phase I pharmacokinetic, safety, and preliminary efficacy study of tiragolumab in combination with atezolizumab in Chinese patients with advanced solid tumors. |
|---|---|
| Authors: | Shemesh CS; Clinical Pharmacology, Genentech Inc., South San Francisco, CA, USA. shemesh.colby@gene.com., Wang Y; Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, China., An A; Safety Science, F. Hoffmann-La Roche Ltd, Beijing, China., Ding H; Clinical Pharmacology, Genentech Inc., South San Francisco, CA, USA., Chan P; Clinical Pharmacology, Genentech Inc., South San Francisco, CA, USA., Liu Q; Clinical Pharmacology, Genentech Inc., South San Francisco, CA, USA., Chen YW; Bioanalytical Science, Genentech Inc., South San Francisco, CA, USA., Wu B; Clinical Pharmacology, Genentech Inc., South San Francisco, CA, USA., Wu Q; Product Development Oncology, F. Hoffmann-La Roche Ltd, Shanghai, China., Wang X; Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou, China. |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2024 Jul; Vol. 94 (1), pp. 45-55. Date of Electronic Publication: 2024 Mar 07. |
| Publication Type: | Journal Article; Clinical Trial, Phase I |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0843 |
|---|---|
| DOI: | 10.1007/s00280-024-04650-y |
